| [1] |
Tran CS,Rangel SM,Almblad H,et al.The Pseudomonas aeruginosa type III translocon is required for biofilm formation at the epithelial barrier[J].PLoS Pathog,2014,10(11):e1004479.DOI: 10.1371/journal.ppat.1004479.
|
| [2] |
Bassetti M,Vena A,Croxatto A,et al.How to manage Pseudomonas aeruginosa infections[J].Drugs Context,2018,7:212527.
|
| [3] |
Hassan R,El-Naggar W,Abd El-Aziz AM,et al.Immunization with outer membrane proteins(OprF and OprI)and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa[J].J Microbiol Immunol Infect, 2018,51(3):312-320.
|
| [4] |
Yu X,Wang Y,Xia YF,et al.A DNA vaccine encoding VP22 of herpes Simplex virus type I(HSV-1)and OprF confers enhanced protection from Pseudomonas aeruginosa in mice[J].Vaccine,2016,34(37):4399-4405.
|
| [5] |
Ullstrom CA,Siehnel R,Woodruff W,et al.Conservation of the gene for outer membrane protein OprF in the family Pseudomonadaceae:sequence of the Pseudomonas syringae oprF gene[J].J Bacteriol, 1991,173(2):768-775.
|
| [6] |
Rello J,Krenn CG,Locker G,et al.A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients[J].Crit Care,2017,21(1):22.
|
| [7] |
Lim S,Koo JH,Choi JM.Use of cell-penetrating peptides in dendritic cell-based vaccination[J].Immune Netw,2016,16(1):33-43.
|
| [8] |
Elliott G,O'Hare P.Intercellular trafficking and protein delivery by a herpesvirus structural protein[J].Cell,1997,88(2):223-233.
|
| [9] |
Zhen S, Takahashi Y, Narita S, et al. Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome[J].Oncotarget,2017,8(6):9375-9387.
|
| [10] |
Chen K,Liu B,Yu B,et al.Advances in the development of aptamer drug conjugates for targeted drug delivery[J].Wiley Interdiscip Rev Nanomed Nanobiotechnol,2017,9(3).doi: 10.1002/wnan.1438.
|
| [11] |
Ganji A,Varasteh A,Sankian M.Aptamers:new arrows to target dendritic cells[J].J Drug Target,2016,24(1):1-12.
|
| [12] |
Lahoud MH,Ahmet F,Zhang JG,et al.DEC-205 is a cell surface receptor for CpG oligonucleotides[J].Proc Natl Acad Sci U S A,2012,109(40):16270-16275.
|
| [13] |
Jiang W,Swiggard WJ,Heufler C,et al.The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing[J].Nature,1995,375(6527):151-155.
|
| [14] |
Wengerter BC,Katakowski JA,Rosenberg JM,et al.Aptamer-targeted antigen delivery[J].Mol Ther,2014,22(7):1375-1387.
|
| [15] |
Allen TM,Sapra P,Moase E.Use of the post-insertion method for the formation of ligand-coupled liposomes[J].Cell Mol Biol Lett,2002,7(3):889-894.
|
| [16] |
Inaba K,Inaba M,Romani N,et al.Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J].J Exp Med,1992, 176(6):1693-1702.
|
| [17] |
Schwendener RA. Liposomes as vaccine delivery systems: a review of the recent advances[J].Ther Adv Vaccines,2014,2(6):159-182.
|
| [18] |
Heurtault B,Saulnier P,Pech B,et al.Physico-chemical stability of colloidal lipid particles[J].Biomaterials,2003,24(23):4283-4300.
|
| [19] |
Xu Y,Shi L,Deng YH.Effect of polyethylene glycol-lipid derivatives on the stability of grafted liposomes[J].Acta Pharm Sin(药学学报),2011,46(10):1178-1186.
|
| [20] |
Fischer D,Bieber T,Li Y,et al.A novel non-viral vector for DNA delivery based on low molecular weight,branched polyethylenimine:effect of molecular weight on transfection efficiency and cytotoxicity[J].Pharm Res,1999,16(8):1273-1279.
|
| [21] |
Villate-Beitia I, Truong NF, Gallego I, et al. Hyaluronic acid hydrogel scaffolds loaded with cationic niosomes for efficient non-viral gene delivery[J].RSC Adv,2018,8(56):31934-31942.
|
| [22] |
Yuan DF,Sun MJ,Wang Y,et al.Preparation and in vitro characterization of octreotide-targeting doxorubicin liposome[J].J China Pharm Univ(中国药科大学学报),2011,42(13):223-229.
|
| [23] |
Kala S,Mak AS,Liu XX,et al.Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer[J].J Med Chem,2014,57(6):2634-2642.
|
| [24] |
Swanson JA.Shaping cups into phagosomes and macropinosomes[J].Nat Rev Mol Cell Biol,2008,9(8):639-649.
|
百度学术
下载:
